Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 101 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SIMONS JM, Maaskant-Braat AJG, Luiten EJT, Leidenius MHK, et al
    Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.
    Eur J Surg Oncol. 2019 Aug 13. pii: S0748-7983(19)30627.
    PubMed     Text format     Abstract available


  2. JAUHARI Y, Gannon MR, Dodwell D, Horgan K, et al
    Addressing frailty in patients with breast cancer: A review of the literature.
    Eur J Surg Oncol. 2019 Aug 12. pii: S0748-7983(19)30623.
    PubMed     Text format     Abstract available


  3. ALTUNDAG K
    Complete response to systemic treatment might predict better survival rates regardless of their metastatic patterns in de novo stage IV breast cancer patients undergoing primary surgery.
    Eur J Surg Oncol. 2019 Aug 8. pii: S0748-7983(19)30618.
    PubMed     Text format    


  4. BEEK MA, Gobardhan PD, Klompenhouwer EG, Menke-Pluijmers MB, et al
    A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Eur J Surg Oncol. 2019 Aug 5. pii: S0748-7983(19)30615.
    PubMed     Text format     Abstract available


    July 2019
  5. CORSO G, Sacchini V, Pravettoni G, Veronesi P, et al
    Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
    Eur J Surg Oncol. 2019 Jul 19. pii: S0748-7983(19)30578.
    PubMed     Text format    


  6. DI MICCO R, Zuber V, Fiacco E, Carriero F, et al
    Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
    Eur J Surg Oncol. 2019 Jul 13. pii: S0748-7983(19)30544.
    PubMed     Text format    


    June 2019
  7. ZACHARIOUDAKIS K, Down S, Bholah Z, Lee S, et al
    Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
    Eur J Surg Oncol. 2019 Jun 26. pii: S0748-7983(19)30529.
    PubMed     Text format     Abstract available


  8. ABBACI M, Conversano A, De Leeuw F, Laplace-Builhe C, et al
    Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review.
    Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30503.
    PubMed     Text format     Abstract available


  9. SZOLLAR A, Ujhelyi M, Polgar C, Olah E, et al
    A long-term retrospective comparative study of the oncological outcomes of 598 very young (</=35 years) and young (36-45 years) breast cancer patients.
    Eur J Surg Oncol. 2019 Jun 5. pii: S0748-7983(19)30498.
    PubMed     Text format     Abstract available


    May 2019
  10. SORRENTINO L, Regolo L, Scoccia E, Petrolo G, et al
    Autologous fat transfer after breast cancer surgery: An exact-matching study on the long-term oncological safety.
    Eur J Surg Oncol. 2019 May 21. pii: S0748-7983(19)30451.
    PubMed     Text format     Abstract available


  11. SAVOLT A, Cserni G, Lazar G, Maraz R, et al
    Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Eur J Surg Oncol. 2019 May 16. pii: S0748-7983(19)30454.
    PubMed     Text format     Abstract available


  12. DRAKE TM, Soreide K
    Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
    Eur J Surg Oncol. 2019;45:736-746.
    PubMed     Text format     Abstract available


    April 2019
  13. RAMSINGH J, O'Dwyer P, Watson C
    Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland.
    Eur J Surg Oncol. 2019;45:631-634.
    PubMed     Text format     Abstract available


  14. FORESTER ND, Lowes S, Mitchell E, Twiddy M, et al
    High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.
    Eur J Surg Oncol. 2019;45:519-527.
    PubMed     Text format     Abstract available


  15. VAN BOCKSTAL M, Lambein K, Smeets A, Slembrouck L, et al
    Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
    Eur J Surg Oncol. 2019;45:550-559.
    PubMed     Text format     Abstract available


    March 2019
  16. SAVAGE P, Yu N, Dumitra S, Meterissian S, et al
    The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication.
    Eur J Surg Oncol. 2019 Mar 23. pii: S0748-7983(19)30355.
    PubMed     Text format     Abstract available


  17. VAN BOCKSTAL MR, Monstrey SJ, van Deurzen CHM
    The role of routine histopathology after chest-contouring surgery in transmen.
    Eur J Surg Oncol. 2019;45:485-486.
    PubMed     Text format    


    February 2019
  18. WANG K, Shi Y, Li ZY, Xiao YL, et al
    Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Eur J Surg Oncol. 2019 Feb 19. pii: S0748-7983(19)30283.
    PubMed     Text format     Abstract available


  19. NIINIKOSKI L, Leidenius MHK, Vaara P, Voynov A, et al
    Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery.
    Eur J Surg Oncol. 2019 Feb 11. pii: S0748-7983(19)30279.
    PubMed     Text format     Abstract available


  20. WALSTRA CJEF, Schipper RJ, Poodt IGM, van Riet YE, et al
    Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.
    Eur J Surg Oncol. 2019 Feb 10. pii: S0748-7983(19)30277.
    PubMed     Text format     Abstract available


  21. RUSSO L, Maltese A, Betancourt L, Romero G, et al
    Locally advanced breast cancer: Tumor-infiltrating lymphocytes as a predictive factor of response to neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2019 Feb 4. pii: S0748-7983(19)30248.
    PubMed     Text format     Abstract available


  22. SORAN A
    Are we close to the end of the primary tumor resection discussion for de novo stage IV BC?
    Eur J Surg Oncol. 2019;45:81-82.
    PubMed     Text format    


  23. ESGUEVA A, Rodriguez-Revuelto R, Espinosa-Bravo M, Salazar JP, et al
    Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries.
    Eur J Surg Oncol. 2019 Feb 1. pii: S0748-7983(19)30040.
    PubMed     Text format     Abstract available


  24. COSTARELLI L, Cianchetti E, Corsi F, Friedman D, et al
    Microinvasive breast carcinoma: An analysis from ten Senonetwork Italia breast centres.
    Eur J Surg Oncol. 2019;45:147-152.
    PubMed     Text format     Abstract available


  25. SUTINEN M, Kontunen A, Karjalainen M, Kiiski J, et al
    Identification of breast tumors from diathermy smoke by differential ion mobility spectrometry.
    Eur J Surg Oncol. 2019;45:141-146.
    PubMed     Text format     Abstract available


  26. KELEMEN P, Pukancsik D, Ujhelyi M, Savolt A, et al
    Comparison of clinicopathologic, cosmetic and quality of life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: A single-centre retrospective study.
    Eur J Surg Oncol. 2019;45:118-124.
    PubMed     Text format     Abstract available


  27. KIM I, Choi HJ, Ryu JM, Lee SK, et al
    A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.
    Eur J Surg Oncol. 2019;45:134-140.
    PubMed     Text format     Abstract available


    January 2019
  28. MICCO RD, Zuber V, Fiacco E, Carriero F, et al
    Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
    Eur J Surg Oncol. 2019 Jan 31. pii: S0748-7983(19)30245.
    PubMed     Text format     Abstract available


  29. OJALA K, Meretoja TJ, Mattson J, Leidenius MHK, et al
    Surgical treatment and prognosis of breast cancer in elderly - A population-based study.
    Eur J Surg Oncol. 2019 Jan 21. pii: S0748-7983(19)30042.
    PubMed     Text format     Abstract available


  30. METS EJ, Chouairi FK, Gabrick KS, Avraham T, et al
    Persistent disparities in breast cancer surgical outcomes among hispanic and African American patients.
    Eur J Surg Oncol. 2019 Jan 17. pii: S0748-7983(19)30039.
    PubMed     Text format     Abstract available


  31. VANE MLG, van Nijnatten TJA, Nelemans PJ, Lobbes MBI, et al
    Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?
    Eur J Surg Oncol. 2019 Jan 14. pii: S0748-7983(19)30035.
    PubMed     Text format     Abstract available


  32. RUBIO IT, Wyld L, Esgueva A, Kovacs T, et al
    Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey.
    Eur J Surg Oncol. 2019 Jan 5. pii: S0748-7983(19)30003.
    PubMed     Text format     Abstract available


  33. BRAHMA B, Yamamoto T
    Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30004.
    PubMed     Text format     Abstract available


  34. VAN EGDOM LSE, Lagendijk M, van der Kemp MH, van Dam JH, et al
    Implementation of Value Based Breast Cancer Care.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30007.
    PubMed     Text format     Abstract available


    December 2018
  35. HEEG E, Schreuder K, Spronk PER, Oosterwijk JC, et al
    Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment.
    Eur J Surg Oncol. 2018 Dec 29. pii: S0748-7983(18)32039.
    PubMed     Text format     Abstract available


  36. QIAO W, Liu H, Guo W, Li P, et al
    Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Dec 25. pii: S0748-7983(18)32041.
    PubMed     Text format     Abstract available


    November 2018
  37. ADAM MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, et al
    Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
    Eur J Surg Oncol. 2018;44:1743-1749.
    PubMed     Text format     Abstract available


  38. AHMEIDAT H, Purdie C, Jordan L, Fleming D, et al
    Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.
    Eur J Surg Oncol. 2018;44:1720-1724.
    PubMed     Text format     Abstract available


  39. LIM GH, Lee J, Yen CC
    Virtual breast oncoplastic surgery simulator (VBOSS): A novel training tool in breast surgery.
    Eur J Surg Oncol. 2018;44:1750-1753.
    PubMed     Text format     Abstract available


  40. FLANAGAN M, Solon J, Chang KH, Deady S, et al
    Peritoneal metastases from extra-abdominal cancer - A population-based study.
    Eur J Surg Oncol. 2018;44:1811-1817.
    PubMed     Text format     Abstract available


  41. YU TJ, Liu YY, Hu X, Di GH, et al
    Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Eur J Surg Oncol. 2018;44:1703-1707.
    PubMed     Text format     Abstract available


    October 2018
  42. HERSI AF, Eriksson S, Ramos J, Abdsaleh S, et al
    A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Eur J Surg Oncol. 2018 Oct 23. pii: S0748-7983(18)31467.
    PubMed     Text format     Abstract available


  43. LAI HW, Wang CC, Lai YC, Chen CJ, et al
    The learning curve of robotic nipple sparing mastectomy for breast cancer: An analysis of consecutive 39 procedures with cumulative sum plot.
    Eur J Surg Oncol. 2018 Oct 17. pii: S0748-7983(18)31440.
    PubMed     Text format     Abstract available


  44. SPRONK PER, Volders JH, van den Tol P, Smorenburg CH, et al
    Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
    Eur J Surg Oncol. 2018 Oct 17. pii: S0748-7983(18)31447.
    PubMed     Text format     Abstract available


  45. HELFGOTT, Mittlbock, Miesbauer, Moinfar, et al
    The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
    Eur J Surg Oncol. 2018 Oct 10. pii: S0748-7983(18)31367.
    PubMed     Text format     Abstract available


  46. DOROGI B, Bukovszky B, Matrai T, Savolt A, et al
    Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases.
    Eur J Surg Oncol. 2018 Oct 7. pii: S0748-7983(18)31418.
    PubMed     Text format     Abstract available


    September 2018
  47. DE FREITAS TB, Lopes de Barros Lima KM, de Andrade Carvalho H, de Azevedo Marques P, et al
    What a difference a clip makes! Analysis of boost volume definition in radiation therapy for conservative breast surgery.
    Eur J Surg Oncol. 2018;44:1312-1317.
    PubMed     Text format     Abstract available


    August 2018
  48. XIAO W, Zou Y, Zheng S, Hu X, et al
    Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Aug 11. pii: S0748-7983(18)31269.
    PubMed     Text format     Abstract available


  49. D'ALONZO M, Pecchio S, Campisi P, De Rosa G, et al
    Nipple-Sparing Mastectomy: Reliability of sub-areolar sampling and frozen section in predicting occult nipple involvement in breast cancer patients.
    Eur J Surg Oncol. 2018 Aug 2. pii: S0748-7983(18)31262.
    PubMed     Text format     Abstract available


  50. CURIGLIANO G
    Inflammatory breast cancer and chest wall disease: The oncologist perspective.
    Eur J Surg Oncol. 2018;44:1142-1147.
    PubMed     Text format     Abstract available


  51. LAI HW, Huang RH, Wu YT, Chen CJ, et al
    Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer - An analysis of 2050 patients.
    Eur J Surg Oncol. 2018 Aug 1. pii: S0748-7983(18)31259.
    PubMed     Text format     Abstract available


    July 2018
  52. POODT IGM, Schipper RJ, Vugts G, Woensdregt K, et al
    The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer.
    Eur J Surg Oncol. 2018 Jul 27. pii: S0748-7983(18)31184.
    PubMed     Text format     Abstract available


  53. HARTLEY RL, Stone JP, Temple-Oberle C
    Breast cancer in transgender patients: A systematic review. Part 1: Male to female.
    Eur J Surg Oncol. 2018 Jul 25. pii: S0748-7983(18)31188.
    PubMed     Text format     Abstract available


  54. STONE JP, Hartley RL, Temple-Oberle C
    Breast cancer in transgender patients: A systematic review. Part 2: Female to Male.
    Eur J Surg Oncol. 2018 Jul 5. pii: S0748-7983(18)31165.
    PubMed     Text format     Abstract available


  55. QIU SQ, Dorrius MD, de Jongh SJ, Jansen L, et al
    Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery.
    Eur J Surg Oncol. 2018 Jul 3. pii: S0748-7983(18)31166.
    PubMed     Text format     Abstract available


  56. MARTA GN, Poortmans P, de Barros AC, Filassi JR, et al
    Reply to: Mastectomy skin flap thickness.
    Eur J Surg Oncol. 2018;44:1119-1120.
    PubMed     Text format    


  57. ROBERTSON SA, Cutress RI
    Mastectomy skin flap thickness.
    Eur J Surg Oncol. 2018;44:1118.
    PubMed     Text format    


  58. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available


  59. DE LORENZI F, Di Bella J, Maisonneuve P, Rotmensz N, et al
    Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.
    Eur J Surg Oncol. 2018;44:957-962.
    PubMed     Text format     Abstract available


  60. TEMPFER CB, Hilal Z, Dogan A, Petersen M, et al
    Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Eur J Surg Oncol. 2018;44:1112-1117.
    PubMed     Text format     Abstract available


  61. ROMICS L, Macaskill EJ, Fernandez T, Simpson L, et al
    A population-based audit of surgical practice and outcomes of oncoplastic breast conservations in Scotland - An analysis of 589 patients.
    Eur J Surg Oncol. 2018;44:939-944.
    PubMed     Text format     Abstract available


    June 2018
  62. KAHLERT S, Kolben TM, Schmoeckel E, Czogalla B, et al
    Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.
    Eur J Surg Oncol. 2018 Jun 23. pii: S0748-7983(18)31136.
    PubMed     Text format     Abstract available


  63. RAFNSDOTTIR SL, Audisio RA
    Inflammatory Breast Cancer: What surgeons need to know.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31128.
    PubMed     Text format     Abstract available


  64. AUDISIO RA
    Inflammatory Breast Cancer: Updates on diagnosis and treatment options.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31123.
    PubMed     Text format    


  65. ALTUNDAG K
    Locally advanced non-inflammatory breast cancer may be misdiagnosed as inflammatory breast cancer.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31122.
    PubMed     Text format    


  66. HARTMANN S, Reimer T, Gerber B, Stubert J, et al
    Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
    Eur J Surg Oncol. 2018 Jun 9. pii: S0748-7983(18)31119.
    PubMed     Text format     Abstract available


    May 2018
  67. ORECCHIA R
    Radiation therapy for inflammatory breast cancer.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31069.
    PubMed     Text format     Abstract available


  68. PAPALOUKA V, Gilbert FJ
    Inflammatory breast cancer-importance of breast imaging.
    Eur J Surg Oncol. 2018 May 16. pii: S0748-7983(18)31058.
    PubMed     Text format    


  69. FENTIMAN IS
    Unmet needs of men with breast cancer.
    Eur J Surg Oncol. 2018 May 15. pii: S0748-7983(18)31054.
    PubMed     Text format     Abstract available


  70. KARAKATSANIS A, Obondo C, Abdsaleh S, Hersi AF, et al
    Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers.
    Eur J Surg Oncol. 2018;44:731-732.
    PubMed     Text format    


  71. HASSING CMS, Tvedskov TF, Kroman N, Klausen TL, et al
    Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.
    Eur J Surg Oncol. 2018;44:725-730.
    PubMed     Text format     Abstract available


  72. MYLVAGANAM S, Conroy EJ, Williamson PR, Barnes NLP, et al
    Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.
    Eur J Surg Oncol. 2018;44:708-716.
    PubMed     Text format     Abstract available


    April 2018
  73. CSERNI G, Charafe-Jauffret E, van Diest PJ
    Inflammatory breast cancer: The pathologists' perspective.
    Eur J Surg Oncol. 2018 Apr 18. pii: S0748-7983(18)30998.
    PubMed     Text format     Abstract available


  74. WICKBERG A, Liljegren G, Killander F, Lindman H, et al
    Omitting radiotherapy in women >/= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007.
    PubMed     Text format     Abstract available


  75. LIM GH, Upadhyaya VS, Acosta HA, Lim JMA, et al
    Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Eur J Surg Oncol. 2018 Apr 12. pii: S0748-7983(18)31008.
    PubMed     Text format     Abstract available


  76. ARISTEI C, Kaidar-Person O, Tagliaferri L, Arenas M, et al
    The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report.
    Eur J Surg Oncol. 2018;44:436-443.
    PubMed     Text format     Abstract available


  77. MAXWELL AJ, Clements K, Hilton B, Dodwell DJ, et al
    Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
    Eur J Surg Oncol. 2018;44:429-435.
    PubMed     Text format     Abstract available


  78. KUERER HM
    Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.
    Eur J Surg Oncol. 2018;44:386-387.
    PubMed     Text format    


  79. LAYEEQUR RAHMAN R, Marshall AJ
    Evidence basis for sentinel node biopsy post neoadjuvant chemotherapy - Bias is a 4-letter word.
    Eur J Surg Oncol. 2018;44:541-542.
    PubMed     Text format    


    March 2018
  80. VICINI E, Invento A, Cuoghi M, Bafile A, et al
    Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30987.
    PubMed     Text format     Abstract available


  81. LAGENDIJK M, van Egdom LSE, Richel C, van Leeuwen N, et al
    Patient reported outcome measures in breast cancer patients.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30954.
    PubMed     Text format     Abstract available


    February 2018
  82. ANGARITA FA, Acuna SA, McCready DR, Escallon J, et al
    Management of positive margins after initial lumpectomy in elderly women with breast cancer.
    Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30671.
    PubMed     Text format     Abstract available


  83. ALTUNDAG K
    Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30118.
    PubMed     Text format    


  84. DE LIGT KM, van Bommel ACM, Schreuder K, Maduro JH, et al
    The effect of being informed on receiving immediate breast reconstruction in breast cancer patients.
    Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30275.
    PubMed     Text format     Abstract available


  85. TASOULIS MK, Iqbal FM, Cawthorn S, MacNeill F, et al
    Reply to: Subcutaneous implant breast reconstruction: The importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:273.
    PubMed     Text format    


  86. ONESTI MG, Fanelli B, Di Taranto G
    Subcutaneous implant breast reconstruction: the importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:271-272.
    PubMed     Text format    


    January 2018
  87. LIAO GS
    Reply letter to: Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Jan 27. pii: S0748-7983(18)30117.
    PubMed     Text format    


  88. SASADA S, Masumoto N, Goda N, Kajitani K, et al
    Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30044.
    PubMed     Text format     Abstract available


  89. QIU SQ, Aarnink M, van Maaren MC, Dorrius MD, et al
    Validation and update of a lymph node metastasis prediction model for breast cancer.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30037.
    PubMed     Text format     Abstract available


  90. ZHAO S, Ma D, Xiao Y, Jiang YZ, et al
    Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
    Eur J Surg Oncol. 2018 Jan 9. pii: S0748-7983(18)30002.
    PubMed     Text format     Abstract available


  91. RUBIO IT
    Variations in the opinion of breast surgeons and radiation oncologist regarding indications for radiation therapy after NSM: The need for prospective studies.
    Eur J Surg Oncol. 2018;44:3-4.
    PubMed     Text format    


  92. RECHT A
    Postmastectomy radiation therapy: What factors are important in recommending treatment to patients undergoing "Sparing" mastectomies.
    Eur J Surg Oncol. 2018;44:1-2.
    PubMed     Text format    


  93. JANSSEN NNY, van la Parra RFD, Loo CE, Groen EJ, et al
    Breast conserving surgery for extensive DCIS using multiple radioactive seeds.
    Eur J Surg Oncol. 2018;44:67-73.
    PubMed     Text format     Abstract available


  94. AHN SK, Han W, Moon HG, Kim MK, et al
    Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.
    Eur J Surg Oncol. 2018;44:53-58.
    PubMed     Text format     Abstract available


  95. NIINIKOSKI L, Hukkinen K, Leidenius MHK, Stahls A, et al
    Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study.
    Eur J Surg Oncol. 2018;44:59-66.
    PubMed     Text format     Abstract available


    December 2017
  96. ONG JSL, Teh J, Saunders C, Bourke AG, et al
    Patient satisfaction with Radioguided Occult Lesion Localisation using iodine-125 seeds ('ROLLIS') versus conventional hookwire localisation.
    Eur J Surg Oncol. 2017;43:2261-2269.
    PubMed     Text format     Abstract available


    November 2017
  97. WESTENEND PJ, Storm R, Kock M, Kitzen J, et al
    The role of ultrasonography of the axilla and fine-needle aspiration cytology in breast cancer patients in the era of neo-adjuvant chemotherapy and axillary radiation; prevention of futile sentinel node procedures revisited.
    Eur J Surg Oncol. 2017 Nov 29. pii: S0748-7983(17)30979.
    PubMed     Text format    


  98. KRISCHER B, Forte S, Niemann T, Kubik-Huch RA, et al
    Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Eur J Surg Oncol. 2017 Nov 26. pii: S0748-7983(17)30978.
    PubMed     Text format     Abstract available


  99. BUNDRED NJ
    Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30539.
    PubMed     Text format    


  100. CHARALAMPOUDIS P, Markopoulos C, Kovacs T
    Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.
    Eur J Surg Oncol. 2017 Nov 13. pii: S0748-7983(17)30955.
    PubMed     Text format     Abstract available


    August 2017
  101. MARTELLI G, Miceli R, Folli S, Guzzetti E, et al
    Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30607.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: